Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
1.
BMC Public Health ; 16: 475, 2016 06 06.
Article in English | MEDLINE | ID: mdl-27268226

ABSTRACT

BACKGROUND: The Programme for the Awareness and Elimination of Diarrhoea (PAED) was a pilot comprehensive diarrhoea prevention and control programme aimed to reduce post-neonatal, all-cause under-five mortality by 15 % in Lusaka Province. Interventions included introduction of the rotavirus vaccine, improved clinical case management of diarrhoea, and a comprehensive community prevention and advocacy campaign on hand washing with soap, exclusive breastfeeding up to 6 months of age, and the use of ORS and Zinc. This study aimed to assess the impact of PAED on under-5 mortality. METHODS: The study was a pre-post evaluation design. The Demographic and Health Survey style population-based two-stage approach was used to collect data at the beginning of the intervention and 3 years following the start of intervention implementation in Lusaka province. The primary outcome of interest was an all-cause, post-neonatal under-five mortality rate defined as the probability of dying after the 28th day and before the fifth birthday among children aged 1-59 months. The Kaplan-Meier time to event analysis was used to estimate the probability of death; multiplying this probability by 1000 to yield the post-neonatal mortality rate. Survival-time inverse probability weighting model was used to estimate Average Treatment Effect (ATE). RESULTS: The percentage of children under age 5 who had diarrhoea in the last 2 weeks preceding the survey declined from 15.8 % (95 % CI: 15.2 %, 16.4 %) in 2012 to 12.7 % (95 % CI: 12.3 %, 13.2 %) in 2015. Over the same period, mortality in post-neonatal children under 5 years of age declined by 34 %, from an estimated rate of 29 deaths per 1000 live births (95 % CI: (26, 32) death per 1000 live births) to 19 deaths per 1000 live births (95 % CI: (16, 21) death per 1000 live births). When every child in the population of children aged 1-59 months is exposed to the intervention, the average time-to-death was estimated to be about 8 months more than when no child is exposed (ATE = 7.9; 95 % CI: 4.4,11.5; P < 0.001). CONCLUSION: Well-packaged diarrhoea preventive and treatment interventions delivered at the clinic and community-level could potentially reduce probability of death among children aged 1-59 months.


Subject(s)
Breast Feeding , Diarrhea, Infantile/prevention & control , Hand Disinfection , Rotavirus Infections/prevention & control , Adolescent , Adult , Child, Preschool , Community Health Services , Diarrhea, Infantile/mortality , Female , Humans , Infant , Infant Mortality , Infant, Newborn , Male , Maternal-Child Health Services , Middle Aged , Rotavirus/immunology , Rotavirus Infections/mortality , Vaccination , Viral Vaccines/administration & dosage , Young Adult , Zambia/epidemiology
2.
Am J Trop Med Hyg ; 92(6): 1227-32, 2015 Jun.
Article in English | MEDLINE | ID: mdl-25870418

ABSTRACT

We evaluated the performance of a point-of-contact circulating cathodic antigen assay (POC-CCA) to detect schistosome infections in primary school children (N = 1,801) living in areas with low, moderate, and high Schistosoma mansoni prevalence in western Kenya. The commercially available assay (CCA-1) and a second, experimental formulation (CCA-2) were compared against Kato-Katz stool examinations and an anti-schistosome enzyme-linked immunosorbent assay (ELISA). A latent class model based on the four tests was used to establish "true infection status" in three different zones based on their distance from Lake Victoria. As a screening tool for community treatment according to World Health Organization (WHO) guidelines, the Kato-Katz examination was in closest agreement with the latent class model, followed by the experimental CCA-2, soluble adult worm antigen preparation (SWAP) ELISA, and CCA-1, which had high sensitivity compared with the other tests but was consistently the least specific. Our experience suggests that POC-CCA tests offer a field-friendly alternative to Kato-Katz, but need further interpretation for appropriate field use.


Subject(s)
Antigens, Protozoan/urine , Reagent Kits, Diagnostic/parasitology , Schistosoma mansoni , Schistosomiasis mansoni/diagnosis , Schools/statistics & numerical data , Animals , Child , Enzyme-Linked Immunosorbent Assay , Feces/parasitology , Female , Humans , Kenya/epidemiology , Lakes/parasitology , Male , Parasite Egg Count , Prevalence , Reagent Kits, Diagnostic/standards , Reproducibility of Results , Schistosomiasis mansoni/epidemiology , Schistosomiasis mansoni/urine , Sensitivity and Specificity
3.
Am J Trop Med Hyg ; 90(2): 322-8, 2014 Feb.
Article in English | MEDLINE | ID: mdl-24323511

ABSTRACT

Recently, health measurements have broadened to include the assessment of quality of life (QOL). This study was conducted to assess whether the short form of the World Health Organization (WHO) QOL questionnaire (WHOQOL-BREF) was an effective tool for measuring morbidity due to Schistosoma mansoni infection and whether it could detect an impact of treatment with praziquantel. A total of 724 adults 18-85 years of age were enrolled. At baseline, S. mansoni prevalence was 73.2% by stool examination and 75.4% by circulating cathodic antigen, and there was no association between infection status and WHOQOL-BREF scores. Six months after treatment, S. mansoni prevalence was lower and the proportion of persons with higher WHOQOL-BREF scores significantly increased among persons who were infected at baseline. However, a similar increase was observed in persons not infected at baseline. In areas of high prevalence, the WHOQOL-BREF may not be able to detect the benefits of schistosomiasis control programs.


Subject(s)
Quality of Life , Schistosomiasis mansoni/drug therapy , Schistosomiasis mansoni/epidemiology , Adolescent , Adult , Aged , Aged, 80 and over , Albendazole/therapeutic use , Animals , Anthropometry , Feces/parasitology , Female , Follow-Up Studies , Humans , Male , Middle Aged , Morbidity , Praziquantel/adverse effects , Praziquantel/therapeutic use , Prevalence , Schistosoma mansoni/isolation & purification , Surveys and Questionnaires , World Health Organization , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL
...